Previous Close | 27.94 |
Open | 28.01 |
Bid | 27.73 x 4000 |
Ask | 27.75 x 4000 |
Day's Range | 27.61 - 28.02 |
52 Week Range | 25.61 - 42.22 |
Volume | |
Avg. Volume | 44,601,030 |
Market Cap | 156.966B |
Beta (5Y Monthly) | 0.56 |
PE Ratio (TTM) | 74.92 |
EPS (TTM) | 0.37 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | 1.68 (6.06%) |
Ex-Dividend Date | Jan 25, 2024 |
1y Target Est | 29.61 |
Subscribe to Yahoo Finance Plus to view Fair Value for PFE
Pfizer is raising around $4.27 billion from the sale of part of its stake in consumer-healthcare business Haleon.
(Bloomberg) -- Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesTrump Rules Out Vivek Ramaswamy as Running Mate as He Eyes New TeamNvidia Unveils Successor to Its All-Conquering AI ProcessorMusk Says His Ketamine Prescription Is in Investors’ Best InterestsEvergrande’s Alleged $78 Billion
Pfizer previously held a 32% stake, followed by second-largest shareholder GSK which has a 4.2% holding. This is Pfizer's first stake sale in Haleon since the company was spun off from GSK and listed in 2022 - three years after its formation by combing the pharma giants' consumer healthcare units. Pfizer said last year it planned to cut its ownership in a "slow and methodical" manner within months.